Systemic injection of recombinant human erythropoietin after focal cerebral ischemia enhances oligodendroglial and endothelial progenitor cells in rat brain

Erythropoietin (EPO) has been demonstrated the ability of recombinant human erythropoietin (r-Hu-EPO), when administered intracerebro-ventricularly, to improve stroke outcome through the reduction of stroke damage. In a brain ischemic model, however, systemic administration of r-Hu-EPO has not been...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young Jae, Jung, Yong-Wook
Formato: Texto
Lenguaje:English
Publicado: Korean Association of Anatomists 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998786/
https://www.ncbi.nlm.nih.gov/pubmed/21189995
http://dx.doi.org/10.5115/acb.2010.43.2.140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998786/
https://www.ncbi.nlm.nih.gov/pubmed/21189995
http://dx.doi.org/10.5115/acb.2010.43.2.140

Ejemplares similares